Display options
Cite
Cirkovic S, Guc-Scekic M, Vujic D, et al. Diagnosis of Fanconi's Anemia by Diepoxybutane Analysis in Children from Serbia. Balkan J Med Genet. 2011;14(2):65-70doi: 10.2478/v10034-011-0048-6.
Cirkovic, S., Guc-Scekic, M., Vujic, D., Ilic, N., Micic, D., Skoric, D., & Jovanovic, A. (2011). Diagnosis of Fanconi's Anemia by Diepoxybutane Analysis in Children from Serbia. Balkan journal of medical genetics : BJMG, 14(2), 65-70. https://doi.org/10.2478/v10034-011-0048-6
Cirkovic, S, et al. "Diagnosis of Fanconi's Anemia by Diepoxybutane Analysis in Children from Serbia." Balkan journal of medical genetics : BJMG vol. 14,2 (2011): 65-70. doi: https://doi.org/10.2478/v10034-011-0048-6
Cirkovic S, Guc-Scekic M, Vujic D, Ilic N, Micic D, Skoric D, Jovanovic A. Diagnosis of Fanconi's Anemia by Diepoxybutane Analysis in Children from Serbia. Balkan J Med Genet. 2011 Dec;14(2):65-70. doi: 10.2478/v10034-011-0048-6. PMID: 24052713; PMCID: PMC3776704.
Copy Download .nbib Format: NLM
Share it on

Balkan J Med Genet. 2011 Dec;14(2):65-70. doi: 10.2478/v10034-011-0048-6.

Diagnosis of Fanconi's Anemia by Diepoxybutane Analysis in Children from Serbia.

Balkan journal of medical genetics : BJMG

S Cirkovic, M Guc-Scekic, D Vujic, N Ilic, D Micic, D Skoric, A Jovanovic

Affiliations

  1. Department of Medical Genetics, Mother and Child Health Care Institute of Serbia "Dr. Vukan Cupic," Belgrade, Serbia.

PMID: 24052713 PMCID: PMC3776704 DOI: 10.2478/v10034-011-0048-6

Abstract

The high sensitivity of Fanconi's anemia (FA) cells to drug induced DNA interstrand crosslinks (ICL) such as diepoxybutane (DEB) was used as a part of FA screening in the children with clinical suspicion of FA. The study considered a total of 66 children with the hematological and/or congenital phenotypic symptoms reminiscent of FA. Blood samples from patients with clinical suspicion of FA and controls were collected for chromosome fragility evaluation by the DEB test. According to the results of DEB test, the patients were divided into two subgroups: FA displaying typical DEB sensitive cellular response and non FA. In this study, 10 out of 66 patients were found to have a FA cellular phenotype. The percentage of DEB-induced aberrant cells was increased more than 26 times in FA patients (range 22.00-82.00% with a mean of 48.32%) when compared to non FA patients (range 0.00-12.00% with a mean of 1.84%). The number of DEB-induced breaks/cells was more than 68 times higher in FA patients (range 0.26-4.39 with a mean of 1.37 breaks/cell) when compared to non FA patients (range 0.00-0.20 with a mean of 0.02 breaks/cell). The spontaneous chromosome fragility values in FA patients were overlapping those in non FA patients. Our results indicate that the DEB sensitivity test is the most reliable in vitro method for verification of the FA cellular phenotype.

Keywords: Chromosome fragility; Diepoxybutane (DEB); Fanconi’s anemia (FA)

References

  1. Annu Rev Genet. 2009;43:223-49 - PubMed
  2. Blood. 2005 Feb 1;105(3):1329-36 - PubMed
  3. Am J Hum Genet. 1988 Oct;43(4):429-35 - PubMed
  4. Blood. 1994 Dec 15;84(12):3995-4007 - PubMed
  5. Nat Genet. 2011 Feb;43(2):138-41 - PubMed
  6. Haematologica. 2010 Aug;95(8):1236-40 - PubMed
  7. J Med Genet. 2011 Apr;48(4):242-50 - PubMed
  8. Blood. 1989 Feb;73(2):391-6 - PubMed
  9. Am J Hematol. 1996 Oct;53(2):99-110 - PubMed
  10. Hum Genet. 1985;69(1):62-5 - PubMed
  11. Hum Genet. 1983;64(4):384-7 - PubMed
  12. Nat Genet. 2010 May;42(5):406-9 - PubMed
  13. Hematology Am Soc Hematol Educ Program. 2004;:318-36 - PubMed
  14. Eur J Hum Genet. 1997 May-Jun;5(3):137-48 - PubMed
  15. Am J Med Genet A. 2004 Jan 1;124A(1):35-9 - PubMed
  16. Biol Chem. 2011 Jul;392(7):625-32 - PubMed
  17. J Korean Med Sci. 1998 Dec;13(6):623-8 - PubMed
  18. Nat Rev Genet. 2007 Oct;8(10):735-48 - PubMed
  19. Cancer Res. 1973 Aug;33(8):1829-36 - PubMed
  20. Nat Genet. 1996 Jul;13(3):255-6 - PubMed
  21. Blood. 1988 Jul;72(1):366-7 - PubMed
  22. Cytogenet Genome Res. 2002;98(2-3):126-35 - PubMed

Publication Types